沉默PD-1基因对AAV8介导的HBV感染大鼠T细胞免疫应答的影响

Effect of silencing PD-1 gene on AAV8-mediated T cell immune response in HBV-infected rats

  • 摘要: 目的 探究沉默PD-1基因对腺相关病毒(AAV)8介导的乙型肝炎病毒(HBV)感染大鼠T细胞免疫应答的影响。方法 选取40只正常大鼠,随机选取10只不做处理,为正常组,其余30只建立AAV8介导的HBV感染大鼠模型,建模成功后,随机选取10只不增加处理,为模型组,将剩余20只模型大鼠分为沉默PD-1组与过表达PD-1组。其中沉默PD-1组进行沉默程序性死亡细胞受体-1(PD-1)干预,过表达PD-1组进行过表达PD-1干预。对大鼠乙型肝炎表面抗原(HBsAg)、乙型肝炎e抗原(HBeAg)水平进行检测与比较,RT-PCR法检测各组大鼠HBV DNA,使用流式细胞仪对CD8+细胞与T细胞表面PD-1分子表达检测及肿瘤坏死因子-α(TNF-α)、干扰素γ(IFN-γ)及Tim3阳性细胞率进行分析。结果 与正常组比较,模型组、过表达PD-1组及沉默PD-1组HBsAg、HBeAg水平均较高,与模型组比较,过表达PD-1组HBsAg、HBeAg水平均较高,沉默PD-1组HBsAg、HBeAg水平均较低(P<0.05);与正常组比较,模型组、过表达PD-1组及沉默PD-1组大鼠肝脏IFN-γ、TNF-α阳性细胞率均较低,Tim3阳性细胞率较高,与模型组比较,过表达PD-1组IFN-γ、TNF-α阳性细胞率均较低,Tim3阳性细胞率较高,沉默PD-1组IFN-γ、TNF-α阳性细胞率均较高,Tim3阳性细胞率较低(P<0.05);与正常组比较,模型组、过表达PD-1组及沉默PD-1组大鼠CD8+淋巴细胞占比均较低,T细胞表面PD-1表达较高,与模型组比较,过表达PD-1组CD8+淋巴细胞占比较低,T细胞表面PD-1表达较高,沉默PD-1组CD8+淋巴细胞占比较高,T细胞表面PD-1表达较低(P<0.05)。结论 在AAV8介导的HBV感染大鼠中进行沉默PD-1基因干预,能够显著肝纤维化进程,提升T细胞的相关活性,对机体内免疫代谢功能进行调节,增强机体抗病毒能力,改善预后,提升机体免疫应答能力,抑制乙型肝炎病毒进展。

     

    Abstract: OBJECTIVE To explore the effect of silencing PD-1 gene on adeno-associated virus(AAV)8-mediated T cell immune response in HBV-infected rats. METHODS A total of 40 normal rats were randomly selected, 10 of which left untreated to be the normal group, and the remaining 30 rats were established to AAV8-mediated HBV infection models.After successful modeling, 10 rats were randomly selected and left untreated to be the model group, and the remaining 20 model rats were divided into the silencing PD-1 group and the overexpression PD-group.Among them, the silencing PD-1 group underwent the silencing programmed death cell receptor-1(PD-1) intervention, and the overexpressing PD-1 group underwent the overexpression PD-1 intervention.The levels of HBsAg and HBeAg of the rats were measured and compared, the HBV DNA of the rats from each group was detected by RT-PCR, and the expression of PD-1 molecules on surfaces of CD8+ cells and T cells were detected by means of flow cytometry, and the positive rates of cells of tumor necrosis factor-α(TNF-α), interferon γ(IFN-γ) and Tim3 were observed. RESULTS The levels of HBsAg and HBeAg of the model group, the overexpression PD-1 group and the silencing PD-1 group were significantly higher than those of the normal group; the levels of HBsAg and HBeAg of the overexpressing PD-1 group were significantly higher than those of the model group, while the levels of HBsAg and HBeAg of the silencing PD-1 group were significantly lower than those of the model group(P<0.05).The positive rates of cells of IFN-γ and TNF-α in livers of the model group, the overexpression PD-1 group and the silencing PD-1 group were significantly lower than those of the normal group, the positive rate of cells of Tim was higher; the positive rates of cells of IFN-γ and TNF-α of the overexpressing PD-1 group were significantly lower than those of the model group, the positive rate of cells of Tim3 was significantly higher, the positive rates of cells of IFN-γ and TNF-α of the silencing PD-1 group were significantly higher than those of the model group, and the positive rate of cells of Tim3 was lower(P< 0.05).As compared with the normal group, the percentage of CD8+ lymphocytes of the model group, the overexpression PD-1 group and the silencing PD-1 group was lower, while the expression level of PD-1 on surfaces of T cells was significantly higher.As compared with the model group, the percentage of CD8+ lymphocytes of the overexpression PD-1 group was lower, and the expression level of PD-1 on surfaces of T cells was higher; the percentage of CD8+ lymphocytes of the silencing PD-1 group was significantly higher, and the expression level of PD-1 on surfaces of T cells was lower(P<0.05). CONCLUSION The intervention to silencing PD-1 gene in the AAV8-mediated rats with HBV infection can significantly improve the progression of liver fibrosis, enhance the relevant activity of T cells, regulate the immune metabolic function in the body, boost the body's antiviral ability, improve the prognosis, enhance the body's immune response ability, and inhibit the progress of hepatitis B virus.

     

/

返回文章
返回